Aspartylglucosaminuria

From Wikipedia, the free encyclopedia

Aspartylglucosaminuria
Classification and external resources
Aspartylglucosamine
ICD-10 E77.1
OMIM 208400
DiseasesDB 952

Aspartylglucosaminuria (AGU), also called aspartylglycosaminuria, is a rare, autosomal recessive[1] metabolic disorder caused by deficient activity of the enzyme aspartylglucosaminidase.

Contents

[edit] Diagnosis

Clinical manifestations consist of psychomotor retardation, grotesque facial appearance, hepatosplenomegaly, ventral hernia and skeletal abnormalities. It is a member of Finnish disease heritage, a group of diseases or syndromes caused by mutation in a single gene characterized by higher frequency in Finland than the rest of the world.[1]

[edit] Pathophysiology

Aspartylglucosaminuria has an autosomal recessive pattern of inheritance.
Aspartylglucosaminuria has an autosomal recessive pattern of inheritance.

Deficiency of aspartylglucosaminidase (1-aspart-amido-beta-N-acetylglucosamine aminohydrase - E.C.3.5.1.26), an enzyme which cleaves the N-acetyl-glucosamine-asparagine linkage of oligosaccharide chains in glycoprotein and glycopeptide metabolism, causes Aspartylglycosaminuria. Biochemical tests show high urinary levels of aspartylglucosamine and low activity of aspartylglucosaminidase.

[edit] Epidemiology

Aspartylglycosaminuria is most common in patients of Finnish ancestry, affecting about 2.5% to 3% of the population.[1]

After trisomy 21 and fragile X syndrome, this is the most frequent multiple congenital anomaly/mental retardation syndrome.[citation needed]

[edit] See also

[edit] References

  1. ^ a b c Aronson NN Jr. (1999). "Aspartylglycosaminuria: biochemistry and molecular biology". Biochim Biophys Acta. 1455 (2-3): 139-154. PMID 10571008. 
Languages